The Thesis

With VIX punching back toward 20, FIIs in their fourth heavy session of selling, and Brent stuck near $107 on persistent Hormuz risk, the book is rotating decisively into defensives. Pharma is doing double duty - earnings insulated from VIX, USD-revenue tailwind from a softer rupee, and immune to the crude squeeze hitting industrial cyclicals. The commodity sleeve (metals, coal, oil) is positioned to capture the inflation pass-through rather than fight it.

Where We're Concentrated

Pharma and healthcare carry seven of thirteen conviction names - the heaviest single-theme tilt this month. Energy and commodity producers form the second cluster. The thesis breaks if Brent cracks below $95 (kills the commodity leg) or if global risk appetite snaps back and FIIs reverse on a single dovish Fed line (defensives derate first).

Conviction Picks

Highest Conviction

Vodafone Idea

A high-beta domestic re-rating candidate that decouples cleanly from FII selling and crude risk - pure India consumption signal.

Defensive Anchor

Biocon

Tied for top conviction - USD-revenue biosimilars play that benefits from rupee weakness while being insulated from the VIX spike.

Commodity Lead

Vedanta

Captures the inflation-pass-through trade - base metals and zinc earnings expand precisely when Brent and INR are pressuring everyone else.

Laurus Labs

Reinforces the pharma cluster with momentum signal - API and CDMO exposure adds an export-earnings hedge against domestic risk-off.

Coal India

High-yield PSU that absorbs the energy-inflation narrative while paying you to wait - a textbook defensive cyclical for this regime.

One Thing to Watch

Brent at $107 with Hormuz still contested. A break above $112 forces a defensive re-rating across the metals/energy sleeve. A clean break below $100 invalidates the commodity leg and rotates conviction back to financials.

BTC briefly dipped below $80K before buyers stepped in, helping the market recover above $80.5K and indicating that near-term support remains active. While price action remains range bound, broader market attention is shifting toward macro developments. The release of the Senate's Clarity Act draft and signs of improving US-China relations through Trump's planned Beijing visit are being followed by the market, including crypto. For Investors, this is not a market environment where being fully deployed is necessary. Maintaining liquidity gives flexibility if markets see deeper corrections or panic-driven selloffs.

Malabar Gold & Diamonds has submitted a comprehensive proposal to the Government of India recommending strategic enhancements to the Gold Monetisation Scheme (GMS), expressing its wholehearted support to Prime Minister Narendra Modi's appeal on responsible gold consumption and the need to strengthen India's economic resilience through better utilisation of domestic gold resources.

Rajesh Palviya, Head of Research, Axis Direct.

The Nifty dropped 436 points yesterday to settle at 23,379.6, marking its fourth consecutive daily loss and a Rs 12-lakh-crore wipeout in investor wealth. Technically, the session's candle was long, bearish, and ended near the lows - showing weak behaviour that decisively broke the 23,800-24,400 consolidation band. Wall Street finished mixed overnight after a hotter-than-expected 3.8% April CPI print, which pushed the Nasdaq 0.7% lower, while the Dow posted small gains; rate-cut bets have diminished. Brent surged near $107 on Iran supply fears, gold held steady around $4,700. Asian futures are soft this morning, and GIFT Nifty indicates a flat open. The battle lines are clear: 23,300 is immediate support, with 23,100-23,000 as the next zone, while bulls need a daily close above 23,500 for any recovery. Unless and until 23,800 is reclaimed, the bias remains bearish. The broader market saw substantial selling pressure, and one can adopt a sell-on-rise strategy until the Nifty surpasses the 23500-23600 level.

Company Reports Strong Q4 & FY26 Performance; Profit Before Tax Rises to Rs 368.58 Crore 

Anant Raj Limited delivered a strong financial performance for Q4 and FY26, driven by robust operational momentum and sustained growth across its real estate portfolio. Additionally, the company announced the appointment of Anish Sarin, Grandson of Ashok Sarin as Director, signalling the induction of next-generation leadership, alongside the constitution of a committee to evaluate potential merger/demerger structures and recommend a strategic roadmap for future growth. 

The company reported significant growth in profitability and strengthened its balance sheet during the year, supported by improved cash flows and healthy investor confidence following the successful QIP raise of approximately Rs. 1,100 crore. For FY26, the company's total assets increased to Rs. 5,590.55 crore from Rs. 4,346.27 crore in FY25, while cash and cash equivalents surged to Rs. 806.90 crore, reflecting enhanced financial strength and liquidity. The Board also recommended a final dividend of Re. 1 per equity share for FY26. 

FY 2026 was characterized by major geo political disruptions starting with the Pahalgam attack & Operation Sindoor in April 2025 with consequent closures of airspace and poor travel sentiment and ended with the onset of the Israel-US-Iran conflict in February 2026 with its continued negative impact on westward bound flights, traveller confidence, limited supply/ rising fuel costs and a rapidly depreciating Rupee Vs major currencies like the USD, Euro and Pound. 

These successive disruptions also coincided with the peak summer booking and travel seasons, resulting in a severely impacted & truncated selling and travel period and also had a cascading price impact with 

significantly higher flight, hotel and travel-related costs affecting leisure, MICE and Business Travel.  

Thomas Cook Standalone PBT (before exceptional items) for FY26 grew by 2% to Rs. 1,690 million as compared to Rs 1,650 million in FY25, despite the challenging environment. 

At the close on Tuesday (May 12), the total market cap of all BSE Sensex companies stood at Rs 4,56,02,922.